SCHEMBL16081646

SCHEMBL16081646

PCCOCCOCCN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CALM1 P0DP23 1/20 0.41
▸ CAMKK2 Q96RR4 1/20 0.41
▸ TSHR P16473 4/20 0.40
▸ ABCB1 P08183 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ GAA P10253 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HDAC3 O15379 2/20 0.37
▸ HDAC1 Q13547 2/20 0.37
▸ HDAC2 Q92769 2/20 0.37
▸ HDAC8 Q9BY41 2/20 0.37
▸ NCOR2 Q9Y618 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ TRPM8 Q7Z2W7 1/20 0.36
▸ TRPV1 Q8NER1 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16081528 0.98 CALM1 (0.42) CALM1CAMKK2TSHRABCB1MAPK1
SCHEMBL12918861 0.91 TSHR (0.45) CALM1CAMKK2TSHRABCB1GAA
SCHEMBL10126562 0.82 HTT (0.47) TSHRABCB1HDAC3HDAC1HDAC2
SCHEMBL22498765 0.82 CARM1 (0.46) CALM1CAMKK2TSHRABCB1SMN1; SMN2
SCHEMBL18073542 0.82 CALM1 (0.44) CALM1CAMKK2TSHRABCB1MAPK1
SCHEMBL10138451 0.82 TSHR (0.47) CALM1CAMKK2TSHRMAPK1GAA
SCHEMBL7692544 0.82 HTT (0.47) TSHRABCB1HDAC3HDAC1HDAC2
SCHEMBL15357270 0.82 CALM1 (0.44) CALM1CAMKK2TSHRABCB1MAPK1
SCHEMBL29467599 0.82 CALM1 (0.44) CALM1CAMKK2TSHRABCB1MAPK1
SCHEMBL14870667 0.82 TSHR (0.47) CALM1CAMKK2TSHRMAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014144017-A2 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS THAT AFFECT EPIDERMIS GENCIA CORPORATION (US) 2014-09-18 — — WO disclosed
Send feedback